Richard Christopher
2017 - ICAD
In 2017, Richard Christopher earned a total compensation of $544.9K as Chief Financial Officer at ICAD, a 172% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $48,250 |
---|---|
Salary | $285,000 |
Stock Awards | $179,666 |
Other | $31,977 |
Total | $544,893 |
Christopher received $285K in salary, accounting for 52% of the total pay in 2017.
Christopher also received $48.3K in non-equity incentive plan, $179.7K in stock awards and $32K in other compensation.
Rankings
In 2017, Richard Christopher's compensation ranked 11,544th out of 14,666 executives tracked by ExecPay. In other words, Christopher earned more than 21.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,544 | 21st |
Manufacturing | 4,528 | 22nd |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 621 | 28th |
Surgical, Medical, And Dental Instruments And Supplies | 367 | 31st |
Surgical and Medical Instruments and Apparatus | 235 | 30th |
Christopher's colleagues
We found two more compensation records of executives who worked with Richard Christopher at ICAD in 2017.
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020